Our data suggest that lncRNA AP001056.1 is a prognosis-related gene for SCCHN, functioning as a tissue-specific eRNA of ICOSLG. With a potential role in immune response, AP001056.1 is a promising therapeutic target for patients with this tumor type when taking subsite into consideration. This evidence concerns the gene ICOSLG and head and neck squamous cell carcinoma.